PDF) Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
UNIVERSIDADE DE LISBOA FACULDADE DE FARMÁCIA STUDY OF THE UNDERLYING BASIS FOR VALPROATE HEPATOTOXICITY: DRUG METABOLISM AND
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration | Journal of Medicinal Chemistry
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials | SpringerLink
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Criteria indicating treatment-resistant schizophrenia, and proxy... | Download Scientific Diagram
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Frontiers | N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
PDF) Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
PDF) Receptor Mechanisms in the treatment of Schizophrenia
Assessing Psychiatric Adverse Effects during Clinical Drug Development | SpringerLink
PDF) N -Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series
Geneesmiddelengebruik in de belgische rusthuizen en rust ... - KCE
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | SpringerLink